Burns Michael S. sold $685K of CSX

CSX reported Q2 FY2026 earnings exceeding Wall Street estimates, with revenue and adjusted EPS above expectations. Shares have seen a 90-day return of 4.88% and a YTD return of 36.23%. The stock's fair value is estimated at $52.85, slightly above its last close of $49.41, with a P/E ratio of 28.4x, leaving valuation debates open.

Apple (AAPL), Q32 Bio (QTTB), and CSX Corp. (CSX) reached 52-week highs. AAPL rose 0.6% to $323.45; Citi raised its target to $365. QTTB surged 90% after positive clinical data; Wells Fargo upgraded it to 'Overweight' with a $66 target. CSX gained 0.4% to $49.90; Raymond James lifted its target to $56. Year-to-date gains: AAPL +16%, CSX +36%, QTTB +543%.

CSX will extend wait times for containers on 25 intermodal lanes to improve network fluidity. Samsung filed a complaint against CMA CGM, seeking $186 million for alleged unfulfilled merchant haulage moves during the pandemic.

Bank of America Securities maintained a Buy rating on CSX with a $56 price target. Wells Fargo also recommended Buy, while Bernstein advised Hold. CSX reported Q2 revenue of $3.94B and net profit of $1B, up from last year. Insider sentiment is negative, with increased selling activity.

A federal appeals court ruled in favor of Zayo Group in a dispute with CSX Transportation over whether CSX can block and charge for fiber optic cable beneath its Indiana rail corridor. The Seventh Circuit held CSX’s easements do not include excluding third parties below ground or above tracks absent disruption. CSX’s standing dismissal was partially reversed, but the outcome stayed.

IMAX, JPMorgan Chase, and CSX shares hit 52-week highs after Wall Street price-target hikes and momentum from recent earnings. IMAX reported Q2 revenue of $102.8M (+12.2% YoY) and adjusted EPS $0.43 (+65%). JPM posted Q2 EPS $7.7 on $57.35B revenue. CSX Q2 revenue rose 10% to $3.94B and diluted EPS to $0.54.